Awaiting product image

Mycophenolate mofetil-cellcept (250 mg, 500 mg)

Roche

“Mycophenolate Mofetil” is the Drug / Molecule content in “Cellcept”. Cellcept belongs to class of dug- immunosuppressive (lowers body’s immune system) which act by inhibiting an enzyme needed for the growth of T cells and B cells. Human body may “reject” an organ transplant when the immune system treats the new organ as an invader. An immunosuppressant helps to prevent this rejection.

Category:

Indication

Cellcept is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Mycophenolate Mofetil also used  in the treatment of autoimmune disease, such as behcet’s disease, pemphigus vulgaris, systemic lupus erythematosus and refractory incomplete lupus erythematosus

Note

Precaution

  • Cellcept is a prescription drug and should be used under proper medical guidance and advice.
  • Increased risk of loss of a pregnancy (miscarriage) and higherrisk of birth defects.
  • Increased risk of getting serious infections.

Related products